Original Article
Copyright ©2011 Baishideng Publishing Group Co.
World J Gastroenterol. Mar 14, 2011; 17(10): 1292-1303
Published online Mar 14, 2011. doi: 10.3748/wjg.v17.i10.1292
Table 2 Univariate and multivariate analyses of prognostic factors for overall survival rate of intrahepatic cholangiocarcinoma patients included in this study
FactornSurvival rate (%)
P value
Hazard ratio95% CI
1-yr3-yrUnivariate analysisMultivariate analyses
Age (yr)
> 652871.433.7
≤ 6512758.331.80.590NANANA
Sex
Female5364.229.4
Male10258.833.70.973NANANA
HBV infection
No6845.620.5
Yes8772.441.80.0030.0444.0750.418-0.987
Cirrhosis
Yes4562.632.7
No1106031.90.964NANANA
Hepatolithiasis
Yes1216.7< 0.01
No14364.334.40.0010.0394.2541.040-4.614
Liver schistosomiasis
Yes757.114.3
No14860.8330.0630.6120.2570.532-2.920
ALT
≤ 42 U/L11360.232.9
> 42 U/L4261.929.80.956NANANA
AST
≤ 37 U/L10258.832.7
> 37 U/L5364.230.50.949NANANA
TBIL
≤ 20 μmol/L11960.530.7
> 20 μmol/L3661.137.50.355NANANA
r-GT
≤ 64 U/L6867.644.7
> 64 U/L8755.222.40.0030.1022.6670.918-2.547
ALP
≤ 119 U/L8971.944.5
> 119 U/L6645.515.8< 0.0010.3860.750.758-2.047
AFP
≤ 20 μg/L12558.432.8
> 20 μg/L307029.30.788NANANA
CA19-9
≤ 37 U/mL6666.741.7
> 37 U/mL8956.224.70.0350.5340.3880.555-1.356
Tumor number
Single13763.536
Multiple1838.911.10.0070.1881.7340.811-2.913
Tumor size
< 5 cm5874.142.1
≥ 5 cm9752.626.10.0140.5630.3350.737-1.754
Tumor location
Left lobe5552.732.2
Right lobe907035.8
Both lobes1020< 0.010.0080.3141.0150.962-1.128
Microscopic satellite lesion
Yes3943.611.5
No11666.438.9< 0.0010.0029.4181.287-3.140
Capsule formation
Yes1764.745.8
No13860.130.50.251NANANA
Tumor differentiation
Well to moderately11861.933.3
Poorly3756.829.50.785NANANA
Vascular invasion
Yes3551.422.2
No12063.336.30.211NANANA
Lymphatic metastasis
Yes3228.13.1
No12369.140.8< 0.0010.0087.0781.193-3.203
Extrahepatic metastasis
Yes1020< 0.01
No14563.433.70.0010.2251.4740.743-3.541
CK19 (n = 153)1
Yes13959.730.5
No1471.445.90.178NANANA